Kyros Ipaktchi
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 13 | 2009 | 237 | 1.780 |
Why?
| Amputation, Traumatic | 6 | 2023 | 22 | 1.440 |
Why?
| Replantation | 6 | 2023 | 33 | 1.380 |
Why?
| p38 Mitogen-Activated Protein Kinases | 5 | 2009 | 262 | 1.120 |
Why?
| Finger Injuries | 2 | 2023 | 21 | 1.040 |
Why?
| Contraindications, Procedure | 1 | 2023 | 11 | 0.890 |
Why?
| Median Nerve | 1 | 2023 | 20 | 0.860 |
Why?
| Laser-Doppler Flowmetry | 1 | 2023 | 32 | 0.860 |
Why?
| Carpal Tunnel Syndrome | 1 | 2023 | 27 | 0.840 |
Why?
| Iatrogenic Disease | 1 | 2023 | 49 | 0.840 |
Why?
| Oximetry | 1 | 2023 | 81 | 0.830 |
Why?
| Radius Fractures | 3 | 2014 | 56 | 0.810 |
Why?
| Wrist Injuries | 3 | 2014 | 25 | 0.650 |
Why?
| Blood-Brain Barrier | 2 | 2009 | 106 | 0.620 |
Why?
| Imidazoles | 3 | 2009 | 211 | 0.590 |
Why?
| Bone Plates | 2 | 2018 | 75 | 0.510 |
Why?
| Pyridines | 3 | 2009 | 425 | 0.500 |
Why?
| Enzyme Inhibitors | 3 | 2007 | 751 | 0.490 |
Why?
| Amputation Stumps | 1 | 2014 | 8 | 0.470 |
Why?
| Complement C5a | 3 | 2009 | 59 | 0.460 |
Why?
| Microsurgery | 2 | 2017 | 59 | 0.450 |
Why?
| Elbow Joint | 2 | 2014 | 59 | 0.430 |
Why?
| Lower Extremity | 2 | 2014 | 335 | 0.420 |
Why?
| Elbow | 1 | 2013 | 52 | 0.410 |
Why?
| Fractures, Malunited | 1 | 2011 | 13 | 0.390 |
Why?
| Mammaplasty | 2 | 2009 | 68 | 0.370 |
Why?
| Bone Transplantation | 1 | 2011 | 98 | 0.360 |
Why?
| Osteotomy | 1 | 2011 | 146 | 0.350 |
Why?
| Dermatitis | 2 | 2007 | 17 | 0.350 |
Why?
| Fractures, Bone | 2 | 2013 | 367 | 0.340 |
Why?
| Brain Edema | 1 | 2009 | 60 | 0.320 |
Why?
| Pituitary Diseases | 1 | 2009 | 23 | 0.320 |
Why?
| Wrist | 2 | 2023 | 48 | 0.320 |
Why?
| Encephalitis | 1 | 2009 | 127 | 0.290 |
Why?
| Physician's Role | 1 | 2009 | 197 | 0.280 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 70 | 0.270 |
Why?
| Forearm | 2 | 2023 | 112 | 0.260 |
Why?
| Sepsis | 2 | 2009 | 508 | 0.260 |
Why?
| Fingers | 2 | 2023 | 83 | 0.250 |
Why?
| Pseudomonas aeruginosa | 1 | 2007 | 298 | 0.240 |
Why?
| Myocardial Contraction | 5 | 2009 | 312 | 0.240 |
Why?
| Self Mutilation | 1 | 2023 | 5 | 0.220 |
Why?
| Rats, Sprague-Dawley | 8 | 2009 | 2209 | 0.220 |
Why?
| Compression Bandages | 1 | 2023 | 5 | 0.220 |
Why?
| Receptor, Anaphylatoxin C5a | 3 | 2009 | 28 | 0.210 |
Why?
| Bandages | 1 | 2023 | 31 | 0.210 |
Why?
| Humans | 27 | 2023 | 114756 | 0.210 |
Why?
| Cytokines | 5 | 2009 | 1843 | 0.210 |
Why?
| Critical Care | 1 | 2006 | 473 | 0.200 |
Why?
| Healthy Volunteers | 1 | 2023 | 197 | 0.200 |
Why?
| Male | 19 | 2023 | 55579 | 0.200 |
Why?
| Clinical Competence | 1 | 2009 | 896 | 0.200 |
Why?
| Pneumonia | 1 | 2007 | 566 | 0.200 |
Why?
| Psychotic Disorders | 1 | 2023 | 118 | 0.200 |
Why?
| Postoperative Care | 1 | 2023 | 219 | 0.200 |
Why?
| Cadaver | 1 | 2023 | 299 | 0.200 |
Why?
| Rats | 9 | 2009 | 4943 | 0.190 |
Why?
| Regional Blood Flow | 1 | 2023 | 424 | 0.190 |
Why?
| Radiography | 2 | 2013 | 811 | 0.170 |
Why?
| Signal Transduction | 3 | 2007 | 4521 | 0.170 |
Why?
| Tomography, X-Ray Computed | 1 | 2009 | 2269 | 0.170 |
Why?
| Orthopedics | 1 | 2021 | 121 | 0.160 |
Why?
| Radial Nerve | 1 | 2019 | 10 | 0.160 |
Why?
| Nerve Transfer | 1 | 2019 | 12 | 0.160 |
Why?
| Vascular Surgical Procedures | 2 | 2021 | 257 | 0.160 |
Why?
| Peripheral Nerve Injuries | 1 | 2019 | 32 | 0.160 |
Why?
| Tendon Transfer | 1 | 2019 | 43 | 0.160 |
Why?
| Metallurgy | 1 | 2018 | 8 | 0.160 |
Why?
| Apoptosis | 2 | 2009 | 2369 | 0.150 |
Why?
| Young Adult | 4 | 2023 | 10463 | 0.150 |
Why?
| Middle Aged | 8 | 2023 | 26757 | 0.150 |
Why?
| Ketones | 1 | 2018 | 45 | 0.150 |
Why?
| Surgeons | 1 | 2021 | 238 | 0.150 |
Why?
| Neurosurgical Procedures | 1 | 2019 | 152 | 0.150 |
Why?
| Metals | 1 | 2018 | 107 | 0.140 |
Why?
| Adult | 8 | 2023 | 30548 | 0.140 |
Why?
| Hand Injuries | 1 | 2017 | 33 | 0.140 |
Why?
| Bone Screws | 1 | 2018 | 114 | 0.140 |
Why?
| Chemokines, CXC | 2 | 2007 | 58 | 0.140 |
Why?
| Sarcomeres | 5 | 2009 | 90 | 0.140 |
Why?
| Administration, Topical | 2 | 2007 | 139 | 0.140 |
Why?
| Burnout, Professional | 1 | 2021 | 322 | 0.130 |
Why?
| Fracture Healing | 2 | 2018 | 76 | 0.130 |
Why?
| Female | 13 | 2023 | 59507 | 0.120 |
Why?
| Resuscitation | 2 | 2008 | 247 | 0.120 |
Why?
| Mycobacterium chelonae | 1 | 2015 | 8 | 0.120 |
Why?
| Skin Diseases, Bacterial | 1 | 2015 | 22 | 0.120 |
Why?
| Adrenergic beta-Antagonists | 2 | 2007 | 287 | 0.120 |
Why?
| Lipopolysaccharides | 5 | 2009 | 812 | 0.120 |
Why?
| Animals | 13 | 2009 | 31761 | 0.120 |
Why?
| Accidents, Traffic | 2 | 2007 | 166 | 0.120 |
Why?
| Abscess | 1 | 2015 | 72 | 0.120 |
Why?
| Debridement | 1 | 2014 | 73 | 0.110 |
Why?
| Wrist Joint | 1 | 2014 | 59 | 0.110 |
Why?
| Polyethylene Glycols | 1 | 2018 | 561 | 0.110 |
Why?
| Joint Diseases | 1 | 2014 | 59 | 0.110 |
Why?
| Upper Extremity | 2 | 2023 | 84 | 0.100 |
Why?
| Skin | 2 | 2007 | 659 | 0.100 |
Why?
| Arthroscopy | 1 | 2014 | 200 | 0.100 |
Why?
| Acute-Phase Proteins | 2 | 2009 | 64 | 0.100 |
Why?
| Myocytes, Cardiac | 4 | 2009 | 448 | 0.090 |
Why?
| Inflammation Mediators | 3 | 2009 | 476 | 0.090 |
Why?
| Hand | 2 | 2021 | 134 | 0.090 |
Why?
| Transplantation, Homologous | 1 | 2011 | 386 | 0.090 |
Why?
| Orthopedic Procedures | 1 | 2013 | 207 | 0.090 |
Why?
| Membrane Glycoproteins | 2 | 2009 | 429 | 0.090 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2015 | 333 | 0.090 |
Why?
| Dermis | 1 | 2009 | 30 | 0.080 |
Why?
| Reoperation | 1 | 2011 | 514 | 0.080 |
Why?
| Proprioception | 1 | 2009 | 19 | 0.080 |
Why?
| Vagus Nerve Stimulation | 1 | 2009 | 21 | 0.080 |
Why?
| Abdominal Wall | 1 | 2009 | 24 | 0.080 |
Why?
| Microcirculation | 1 | 2009 | 135 | 0.080 |
Why?
| Smoke Inhalation Injury | 1 | 2008 | 19 | 0.080 |
Why?
| Epidermis | 1 | 2009 | 149 | 0.080 |
Why?
| Macrophage Migration-Inhibitory Factors | 1 | 2008 | 10 | 0.080 |
Why?
| Leukotriene B4 | 1 | 2008 | 48 | 0.080 |
Why?
| Carrier Proteins | 2 | 2009 | 696 | 0.080 |
Why?
| Surgical Flaps | 1 | 2009 | 121 | 0.080 |
Why?
| HMGB1 Protein | 1 | 2008 | 48 | 0.080 |
Why?
| Recovery of Function | 1 | 2011 | 572 | 0.070 |
Why?
| Fluid Therapy | 1 | 2008 | 122 | 0.070 |
Why?
| Klebsiella Infections | 1 | 2007 | 23 | 0.070 |
Why?
| Chemokine CXCL2 | 1 | 2007 | 37 | 0.070 |
Why?
| Colony-Forming Units Assay | 1 | 2007 | 89 | 0.070 |
Why?
| Klebsiella pneumoniae | 1 | 2007 | 41 | 0.070 |
Why?
| Shoulder Joint | 1 | 2009 | 159 | 0.070 |
Why?
| Neutrophil Infiltration | 1 | 2007 | 94 | 0.070 |
Why?
| Wound Healing | 1 | 2009 | 258 | 0.070 |
Why?
| Anabolic Agents | 1 | 2006 | 11 | 0.070 |
Why?
| Aged | 4 | 2013 | 19094 | 0.070 |
Why?
| Oxandrolone | 1 | 2006 | 8 | 0.070 |
Why?
| Ventricular Dysfunction, Left | 2 | 2007 | 359 | 0.070 |
Why?
| Preoperative Care | 1 | 2009 | 317 | 0.070 |
Why?
| Nutritional Support | 1 | 2006 | 27 | 0.070 |
Why?
| Interleukin-6 | 2 | 2009 | 675 | 0.070 |
Why?
| Ventricular Function, Left | 1 | 2009 | 467 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2009 | 1846 | 0.070 |
Why?
| Pseudomonas Infections | 1 | 2007 | 184 | 0.060 |
Why?
| Complement Activation | 1 | 2008 | 340 | 0.060 |
Why?
| Kupffer Cells | 1 | 2005 | 45 | 0.060 |
Why?
| Complement System Proteins | 1 | 2008 | 285 | 0.060 |
Why?
| Collagen | 1 | 2007 | 415 | 0.060 |
Why?
| Heart Failure | 2 | 2009 | 1952 | 0.060 |
Why?
| Immunoglobulin G | 1 | 2009 | 774 | 0.060 |
Why?
| Gene Expression | 2 | 2006 | 1420 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 928 | 0.060 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 797 | 0.060 |
Why?
| Fracture Fixation, Internal | 2 | 2018 | 194 | 0.060 |
Why?
| Mice | 4 | 2008 | 14916 | 0.060 |
Why?
| Hip Injuries | 1 | 2004 | 16 | 0.060 |
Why?
| Protein Kinase Inhibitors | 1 | 2009 | 795 | 0.060 |
Why?
| Disease Models, Animal | 3 | 2008 | 3542 | 0.060 |
Why?
| Hip | 1 | 2004 | 46 | 0.060 |
Why?
| Phagocytosis | 1 | 2005 | 350 | 0.050 |
Why?
| Mice, Inbred C57BL | 3 | 2008 | 4710 | 0.050 |
Why?
| Follow-Up Studies | 1 | 2011 | 4420 | 0.050 |
Why?
| Immunotherapy | 1 | 2006 | 475 | 0.050 |
Why?
| Risk Assessment | 1 | 2011 | 2973 | 0.050 |
Why?
| Cholestasis | 1 | 2005 | 224 | 0.050 |
Why?
| Cardiomyopathies | 1 | 2005 | 298 | 0.050 |
Why?
| Nitric Oxide | 1 | 2007 | 824 | 0.050 |
Why?
| Clinical Protocols | 1 | 2023 | 232 | 0.050 |
Why?
| Cohort Studies | 1 | 2011 | 4901 | 0.050 |
Why?
| Review Literature as Topic | 1 | 2021 | 61 | 0.050 |
Why?
| Fibrinolytic Agents | 1 | 2023 | 233 | 0.050 |
Why?
| Neutrophils | 1 | 2006 | 1163 | 0.050 |
Why?
| Epithelial Cells | 1 | 2006 | 955 | 0.050 |
Why?
| Schools, Medical | 1 | 2021 | 120 | 0.040 |
Why?
| Treatment Outcome | 2 | 2011 | 9089 | 0.040 |
Why?
| Range of Motion, Articular | 2 | 2014 | 351 | 0.040 |
Why?
| Job Satisfaction | 1 | 2021 | 168 | 0.040 |
Why?
| Retrospective Studies | 3 | 2011 | 12515 | 0.040 |
Why?
| Wounds and Injuries | 1 | 2007 | 723 | 0.040 |
Why?
| Evidence-Based Medicine | 1 | 2023 | 667 | 0.040 |
Why?
| Anticoagulants | 1 | 2023 | 547 | 0.040 |
Why?
| Biomarkers | 1 | 2009 | 3416 | 0.040 |
Why?
| Lung | 2 | 2008 | 3546 | 0.040 |
Why?
| Benzophenones | 1 | 2018 | 16 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2021 | 4625 | 0.040 |
Why?
| Open Fracture Reduction | 1 | 2018 | 24 | 0.040 |
Why?
| Postoperative Complications | 2 | 2023 | 2127 | 0.040 |
Why?
| Hospitals | 1 | 2021 | 580 | 0.030 |
Why?
| Materials Testing | 1 | 2018 | 337 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2018 | 445 | 0.030 |
Why?
| Inflammation | 1 | 2006 | 2481 | 0.030 |
Why?
| Ulna Fractures | 1 | 2014 | 13 | 0.030 |
Why?
| Therapeutic Irrigation | 1 | 2015 | 67 | 0.030 |
Why?
| Recombinant Proteins | 2 | 2009 | 1233 | 0.030 |
Why?
| Antibodies | 2 | 2007 | 371 | 0.030 |
Why?
| Polymers | 1 | 2018 | 447 | 0.030 |
Why?
| Joint Dislocations | 1 | 2014 | 56 | 0.030 |
Why?
| Contraindications | 1 | 2014 | 85 | 0.030 |
Why?
| Drainage | 1 | 2015 | 151 | 0.030 |
Why?
| Cells, Cultured | 3 | 2006 | 3890 | 0.030 |
Why?
| Adolescent | 1 | 2011 | 17808 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2015 | 1122 | 0.020 |
Why?
| Case-Control Studies | 2 | 2009 | 3005 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2021 | 1812 | 0.020 |
Why?
| Sex Factors | 2 | 2007 | 1717 | 0.020 |
Why?
| In Situ Nick-End Labeling | 1 | 2009 | 119 | 0.020 |
Why?
| Trauma Severity Indices | 1 | 2008 | 110 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2009 | 305 | 0.020 |
Why?
| Anthropometry | 1 | 2008 | 183 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2008 | 271 | 0.020 |
Why?
| Air Bags | 1 | 2007 | 2 | 0.020 |
Why?
| Seat Belts | 1 | 2007 | 18 | 0.020 |
Why?
| Time Factors | 2 | 2008 | 6124 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2009 | 370 | 0.020 |
Why?
| Pressure | 1 | 2007 | 218 | 0.020 |
Why?
| Regression Analysis | 1 | 2008 | 946 | 0.020 |
Why?
| Body Height | 1 | 2007 | 180 | 0.020 |
Why?
| Base Sequence | 1 | 2009 | 2118 | 0.020 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 589 | 0.020 |
Why?
| Heart Rate | 1 | 2009 | 704 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2015 | 1477 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2005 | 59 | 0.020 |
Why?
| United States | 1 | 2021 | 12176 | 0.020 |
Why?
| Craniocerebral Trauma | 1 | 2007 | 128 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 684 | 0.020 |
Why?
| Safety | 1 | 2007 | 297 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2009 | 2791 | 0.020 |
Why?
| Blotting, Western | 1 | 2007 | 1151 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 994 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2009 | 1134 | 0.010 |
Why?
| Myocardium | 1 | 2009 | 908 | 0.010 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 242 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2005 | 1013 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2015 | 3039 | 0.010 |
Why?
| Finite Element Analysis | 1 | 2004 | 66 | 0.010 |
Why?
| Survival Analysis | 1 | 2007 | 1218 | 0.010 |
Why?
| Multivariate Analysis | 1 | 2007 | 1435 | 0.010 |
Why?
| Alcohol Drinking | 1 | 2008 | 654 | 0.010 |
Why?
| Body Weight | 1 | 2007 | 869 | 0.010 |
Why?
| Logistic Models | 1 | 2007 | 1843 | 0.010 |
Why?
| Algorithms | 1 | 2008 | 1468 | 0.010 |
Why?
| Liver | 1 | 2009 | 1631 | 0.010 |
Why?
| Practice Guidelines as Topic | 1 | 2008 | 1393 | 0.010 |
Why?
| Biomechanical Phenomena | 1 | 2004 | 667 | 0.010 |
Why?
| Endothelial Cells | 1 | 2005 | 681 | 0.010 |
Why?
| Child | 1 | 2017 | 18352 | 0.010 |
Why?
| RNA, Messenger | 1 | 2005 | 2557 | 0.010 |
Why?
| Phenotype | 1 | 2005 | 2812 | 0.010 |
Why?
|
|
Ipaktchi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|